Published in Arch Dermatol on September 01, 1971
Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest (1977) 2.07
Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor. J Clin Invest (1979) 1.01
Cutaneous vasculitis and immune complexes in severe bronchiectasis. Thorax (1984) 0.90
Immunoglobulin and complement in normal skin. J Clin Pathol (1978) 0.89
Cutaneous vasculitis: a presenting feature in Hodgkin's disease. J R Soc Med (1986) 0.83
An aetiological & clinicopathological study on cutaneous vasculitis. Indian J Med Res (2012) 0.81
[Erythema elevatum diutinum. II. Immunoelectronmicroscopical study of leukocytoclastic vasculitis within the intracutaneous test reaction induced by streptococcal antigen (author's transl)]. Arch Dermatol Res (1978) 0.78
Immunofluorescent investigations in cutaneous vasculitis. I. Histotopical demonstration of complement/complement factors. Arch Dermatol Res (1975) 0.78
[Light microscopic demonstration of peroxidase labelled antibodies in passive Arthus-phenomenon (author's transl)]. Arch Dermatol Forsch (1973) 0.77
Symptoms and immunology of the Henoch-Schönlein-syndrome. Arch Dermatol Res (1976) 0.75
Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol (1968) 16.77
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Pyoderma gangrenosum: a review of 86 patients. Q J Med (1985) 3.08
Gonorrhea. Ann Intern Med (1970) 2.95
Gonorrhea--diagnosis and treatment. Obstet Gynecol (1972) 2.91
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. Mayo Clin Proc (1973) 2.56
Therapy for incubating syphilis. Effectiveness of gonorrhea treatment. JAMA (1971) 2.27
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis. Arch Dermatol (1967) 2.15
Herpes simplex infections in hematologic malignancies. Am J Med (1972) 2.13
Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clin Proc (1995) 2.12
Treatment for early syphilis and reactivity of serologic tests. JAMA (1972) 2.07
Kaposi's sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine (Baltimore) (1965) 2.04
Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol (1989) 1.84
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc (1968) 1.67
A quantitative study of Meissner's corpuscles in man. Neurology (1966) 1.55
Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol (1996) 1.54
Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma. Arch Dermatol (2001) 1.53
Leukocytoclastic vasculitis. Arch Dermatol (1976) 1.52
Necrotizing vasculitis. J Am Acad Dermatol (1980) 1.52
Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) (1968) 1.50
Immunologic mechanisms in systemic vasculitis. Mayo Clin Proc (1976) 1.50
Necrotizing vasculitis and atherosclerosis. Br J Dermatol (1988) 1.49
Vasculitis and retinoids. Lancet (1989) 1.49
Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria. J Am Acad Dermatol (1989) 1.48
Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis. Antimicrob Agents Chemother (1979) 1.48
Tests for treponemal antibody in CSF. Arch Intern Med (1978) 1.48
Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol (1986) 1.47
Histiocytic cytophagic panniculitis. J Am Acad Dermatol (1989) 1.46
Erythema ab igne: a histopathological study. J Invest Dermatol (1966) 1.46
Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985. Mayo Clin Proc (1990) 1.42
Fatal systemic cytophagic histiocytic panniculitis: a histopathologic and immunohistochemical study of multiple organ sites. J Am Acad Dermatol (1994) 1.39
Cancer and scleroderma. Arch Dermatol (1979) 1.39
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
The rectal culture as a test of cure of gonorrhea in the female. J Infect Dis (1972) 1.39
Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant. J Am Acad Dermatol (1988) 1.38
Cutaneous vessel immune deposits in rheumatoid arthritis. Arthritis Rheum (1976) 1.38
Episodic angioedema associated with eosinophilia. N Engl J Med (1984) 1.38
Ophthalmic features of necrobiotic xanthogranuloma with paraproteinemia. Am J Ophthalmol (1984) 1.37
Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Ann Intern Med (1980) 1.37
Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol (1983) 1.36
Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol (1996) 1.35
Generalized plane xanthoma and systemic disease. Arch Dermatol (1966) 1.34
Histopathologic findings in anetoderma. Arch Dermatol (1984) 1.34
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Erythroderma with atypical lymphocytes. (Sézary syndrome). Am J Med (1973) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Studies of the antibodies in pemphigoid and pemphigus. J Lab Clin Med (1973) 1.31
Quantitative studies on the Langerhans cell population of guinea pig epidermis. J Invest Dermatol (1967) 1.31
Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome. Arch Dermatol (1974) 1.30
Prostaglandins and chemotaxis: enhancement of polymorphonuclear leukocyte chemotaxis by prostaglandin F2alpha. J Invest Dermatol (1976) 1.30
Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol (1980) 1.28
Papulonecrotic tuberculid: a neglected disease in Western countries. J Am Acad Dermatol (1986) 1.27
Bullous pyoderma gangrenosum and leukemia. Arch Dermatol (1972) 1.27
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
Necrobiotic xanthogranuloma. Arch Dermatol (1992) 1.25
Dermatofibrosarcoma protuberans. Study of fifty-six cases. Am J Surg (1966) 1.24
Effect of a nitro-imidazole on primary experimental syphilis in rabbits. Br J Vener Dis (1966) 1.24
Untoward response with topical fluorouracil. Arch Dermatol (1968) 1.24
Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases. Medicine (Baltimore) (1986) 1.24
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol (1998) 1.24
Panniculitis in connective tissue disease. Arch Dermatol (1983) 1.23
An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol (1982) 1.23
Esophageal deterioration in scleroderma. Mayo Clin Proc (1971) 1.23
The Merkel cell. J Invest Dermatol (1973) 1.22
Ultrastructural localization of nucleoside triphosphatase in Langerhans cells. J Invest Dermatol (1967) 1.22
Necrotising vasculitis associated with lethal reticuloendothelial diseases. Br J Dermatol (1968) 1.21
Necrobiotic xanthogranuloma. Australas J Dermatol (1980) 1.21
Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol (1988) 1.20
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
The skin in histiocytosis X. Mayo Clin Proc (1969) 1.20
Panniculitis and systemic lupus erythematosus. JAMA (1970) 1.19
Classification and pathogenesis of scleroderma. Mayo Clin Proc (1971) 1.19
Cutaneous periarteritis nodosa. Arch Dermatol (1974) 1.19
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
Antinuclear antibodies in primary biliary cirrhosis. Lancet (1984) 1.17
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
The affinity of melanin for chloroquine. J Invest Dermatol (1965) 1.17
Effect of urinary pH on excretion of porphyrins. Lancet (1966) 1.16
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
Generalized eruptive histiocytoma. Enzyme histochemistry and electron microscopy. Arch Dermatol (1967) 1.14
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14